找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Vascular Malformations; Ajay K. Khanna,Satyendra K. Tiwary Book 2021 Springer Nature Singapore Pte Ltd. 2021 Investigations in vascular ma

[復(fù)制鏈接]
樓主: Coenzyme
11#
發(fā)表于 2025-3-23 10:26:25 | 只看該作者
Alexis M. Yakes,Alexander J. Continenza,Wayne F. Yakes
12#
發(fā)表于 2025-3-23 15:13:24 | 只看該作者
13#
發(fā)表于 2025-3-23 20:51:40 | 只看該作者
Approach to a Case of Vascular Malformation, Radiological interventions have become the mainstay of treatment for many a case, however, the role of conventional surgery is still defined and reconstructive methods are evolving to deal with the challenges afforded by these malformations.
14#
發(fā)表于 2025-3-24 01:56:31 | 只看該作者
15#
發(fā)表于 2025-3-24 04:39:45 | 只看該作者
Capillary Malformation,sociation with capillary malformations which may be syndromic or non-syndromic depending upon the time of mutation during the developmental process. The non-syndromic lesions which are cosmetically insignificant do not require any intervention. The decision to treat a patient of CM depends on multip
16#
發(fā)表于 2025-3-24 08:14:27 | 只看該作者
17#
發(fā)表于 2025-3-24 12:34:01 | 只看該作者
Combined Vascular Malformation,skeletal anomalies comprise another newly recognized syndrome named congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal anomalies (CLOVES) syndrome. Diagnosis of combined vascular malformation includes clinical evaluation, duplex scanning, radiography, MRI with con
18#
發(fā)表于 2025-3-24 18:41:12 | 只看該作者
Embryology of Vascular Malformation,he fact that all the mature and named vessels originate from their precursor i.e. embryonic vessels and any vascular anomalies is closely correlated with its development This chapter has tried to cover the development of arterial, venous and lymphatic system and its associated anomalies.?
19#
發(fā)表于 2025-3-24 22:49:53 | 只看該作者
Surgical Treatment in Vascular Malformations,atment. Currently, the surgical treatment for the CVMs including AVMs, VMs, and LMs remain the adjunctive options as multidisciplinary treatment principles and the last or completion option following embolosclerotherapy or failed endovascular treatment.
20#
發(fā)表于 2025-3-25 02:27:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 12:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
洛宁县| 漳浦县| 玉树县| 遂溪县| 增城市| 九龙县| 天水市| 高安市| 红河县| 谢通门县| 无为县| 亳州市| 公主岭市| 万盛区| 兴宁市| 兴城市| 肇州县| 嵩明县| 比如县| 山东省| 安远县| 莒南县| 苏尼特左旗| 平阳县| 黎城县| 柳江县| 平原县| 四川省| 昌江| 宝丰县| 玛多县| 高邮市| 兴文县| 东乌| 岑巩县| 库车县| 涡阳县| 公主岭市| 偃师市| 砀山县| 宜阳县|